Clinical trial NCT04116411 - References

Glioblastoma Multiforme — A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients

Citation(s)

•   Cobbs CS
  Does valganciclovir have a role in glioblastoma therapy? Neuro Oncol. 2014 Mar;16(3):330-1. doi: 10.1093/neuonc/nou009.
•   Peredo I, Helldén A, Wolmer-Solberg N, Pohanka A, Stragliotto G, Rahbar A, Ståhle L, Bellander BM, Söderberg-Nauclér C
  Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study. BMJ Case Rep. 2015 Dec 15;2015. pii: bcr2014207694. doi: 10.1136/bcr-2014-207694.
•   Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Strååt K, Stragliotto G, Söderberg-Nauclér C
  Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol. 2013 May;57(1):36-42. doi: 10.1016/j.jcv.2012.12.018. Epub 2013 Feb 4.
•   Söderberg-Nauclér C, Peredo I, Stragliotto G
  Valganciclovir in patients with glioblastoma. N Engl J Med. 2013 Nov 21;369(21):2066-7. doi: 10.1056/NEJMc1312413.
•   Stragliotto G, Rahbar A, Solberg NW, Lilja A, Taher C, Orrego A, Bjurman B, Tammik C, Skarman P, Peredo I, Söderberg-Nauclér C
  Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-bli

A Multicenter Randomized Double-blinded Controlled Phase 2 Study Evaluating the Efficacy of Valganciclovir as add-on Therapy in Glioblastoma Patients

Details for clinical trial NCT04116411